US 11559567
Dosage regimen for pegylated interferon
granted A61KA61K38/21A61K38/212
Quick answer
US patent 11559567 (Dosage regimen for pegylated interferon) held by PHARMAESSENTIA CORPORATION expires Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- PHARMAESSENTIA CORPORATION
- Grant date
- Tue Jan 24 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 19 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K38/21, A61K38/212, A61K47/60, A61P